US FDA Approved Novel Drugs for Year 2020
admin Admission Alerts Abametapir To treat head lice, Amisulpride To help prevent nausea and vomiting after surgery, and Odesivimab-ebgn To treat ebola virus, Ansuvimab-zykl To treat ebola, Atoltivimab, Belantamab mafodotin-blmf To treat multiple myeloma, Berotralstat To treat patients with hereditary angioedema, Clascoterone To treat acne, Copper Cu 64 dotatate injection To help detect certain types of neuroendocrine tumors, Decitabine and Cedazuridine To treat adult patients with myelodysplastic syndromes, Fostemsavir To treat HIV, Gallium 68 PSMA-11 For detection and localization of prostate cancer, Lonafarnib To treat rare conditions related to premature aging, Lumasiran To treat hyperoxaluria type 1, Maftivimab, Margetuximab (anti-HER2 mAb To treat HER2+ breast cancer, Naxitamab-gqgk To treat high-risk refractory or relapsed neuroblastoma, New Drugs approved in Year 2020, New Drugs approved in Year 2020 by USFDA, Nifurtimox To treat Chagas disease, Novel Drugs Approved for Year 2020, Oliceridine To manage acute pain in certain adults, Pralsetinib To treat non-small lung cancer, Relugolix To treat advanced prostate cancer, Remdesivir To treat COVID-19, Remimazolam For treatment of sedation, Rimegepant To treat migraine, Risdiplam To treat spinal muscular atrophy, Setmelanotide To treat obesity, Tafasitamab-cxix To treat relapsed or refractory diffuse large B-cell lymphoma, Tirbanibulin To treat actinic Keratosis of the face or scalp, Triheptanoin To treat molecularly long-chain fatty acid oxidation disorders, Vibegron for To treat overactive bladder, Viltolarsen To treat Duchenne muscular dystrophy
Find the list of Approved new drug ingredient which are approved by US FDA in year 2020
| No. | Active Ingredient | FDA-approved use on approval date* | Approval Date | ||
| 1 | Vibegron | To treat overactive bladder | 12/23/2020 | ||
| 2 | Ansuvimab-zykl | To treat ebola | 12/21/2020 | ||
| 3 | Relugolix | To treat advanced prostate cancer | 12/18/2020 | ||
| 4 | Margetuximab (anti-HER2 mAb | To treat HER2+ breast cancer | 12/16/2020 | ||
| 5 | Tirbanibulin | To treat actinic Keratosis of the face or scalp | 12/14/2020 | ||
| 6 | Berotralstat | To treat patients with hereditary angioedema | 12-03-2020 | ||
| 7 | Gallium 68 PSMA-11 | For detection and localization of prostate cancer | 12-01-2020 | ||
| 8 | Naxitamab-gqgk | To treat high-risk refractory or relapsed neuroblastoma | 11/25/2020 | ||
| 9 | Setmelanotide | To treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency, a rare disorder that causes severe obesity that begins at an early age | 11/25/2020 | ||
| 10 | Lumasiran | To treat hyperoxaluria type 1 | 11/23/2020 | ||
| 11 | Lonafarnib | To treat rare conditions related to premature aging | 11/20/2020 | ||
| 12 | Remdesivir | To treat COVID-19 | 10/22/2020 | ||
| 13 | Atoltivimab, Maftivimab, and Odesivimab-ebgn | To treat ebola virus | 10/14/2020 | ||
| 14 | Pralsetinib | To treat non-small lung cancer | 09-04-2020 | ||
| 15 | Copper Cu 64 dotatate injection | To help detect certain types of neuroendocrine tumors | 09-03-2020 | ||
| 16 | Somapacitan-beco | Growth hormone | 8/28/2020 | ||
| 17 | Clascoterone | To treat acne | 8/26/2020 | ||
| 18 | Satralizumab-mwge | To treat neuromyelitis optica spectrum disorder | 8/14/2020 | ||
| 19 | Viltolarsen | To treat Duchenne muscular dystrophy | 08-12-2020 | ||
| 20 | Oliceridine | To manage acute pain in certain adults | 08-07-2020 | ||
| 21 | Risdiplam | To treat spinal muscular atrophy | 08-07-2020 | ||
| 22 | Nifurtimox | To treat Chagas disease in certain pediatric patients younger than age 18 | 08-06-2020 | ||
| 23 | Belantamab mafodotin-blmf | To treat multiple myeloma | 08-05-2020 | ||
| 24 | Tafasitamab-cxix | To treat relapsed or refractory diffuse large B-cell lymphoma | 7/31/2020 | ||
| 25 | Abametapir | To treat head lice | 7/24/2020 | ||
| 26 | Decitabine and Cedazuridine | To treat adult patients with myelodysplastic syndromes | 07-07-2020 | ||
| 27 | Fostemsavir | To treat HIV | 07-02-2020 | ||
| 28 | Remimazolam | For sedation | 07-02-2020 | ||
| 29 | Triheptanoin | To treat molecularly long-chain fatty acid oxidation disorders | 6/30/2020 | ||
| 30 | Lurbinectedin | To treat metastatic small cell lung cancer | 6/15/2020 | ||
| 31 | Inebilizumab-cdon | To treat neuromyelitis optica spectrum disorder | 06-11-2020 | ||
| 32 | Flortaucipir F18 | Diagnostic agent for patients with Alzheimer’s disease | 5/28/2020 | ||
| 33 | Artesunate | To treat severe malaria | 5/26/2020 | ||
| 34 | Fluoroestradiol F18 | Diagnostic imaging agent for certain patients with breast cancer | 5/20/2020 | ||
| 35 | Ripretinib | To treat advanced gastrointestinal-stromal tumors | 5/15/2020 | ||
| 36 | Selpercatinib | To treat lung and thyroid cancers | 05-08-2020 | ||
| 37 | Capmatinib | To treat patients with non small cell lung cancer | 05-06-2020 | ||
| 38 | Opicapone | To treat patients with Parkinson’s disease experiencing “off” episodes | 4/24/2020 | ||
| 39 | Sacituzumab govitecan-hziy | To treat adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease | 4/22/2020 | ||
| 40 | Pemigatinib | To treat certain patients with cholangiocarcinoma, a rare form of cancer that forms in bile ducts | 4/17/2020 | ||
| 41 | Tucatinib | To treat advanced unresectable or metastatic HER2-positive breast cancer | 4/17/2020 | ||
| 42 | Selumetinib | To treat neurofibromatosis type 1, a genetic disorder of the nervous system causing tumors to grow on nerves | 04-10-2020 | ||
| 43 | Ozanimod | To treat relapsing forms of multiple sclerosis | 3/25/2020 | ||
| 44 | Osilodrostat | To treat adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease | 03-06-2020 | ||
| 45 | Isatuximab | To treat multiple myloma | 03-02-2020 | ||
| 46 | Rimegepant | To treat migraine | 2/27/2020 | ||
| 47 | Amisulpride | To help prevent nausea and vomiting after surgery | 2/26/2020 | ||
| 48 | Eptinezumab-jjmr | For the preventive treatment of migraine in adults | 2/21/2020 | ||
| 49 | Bempedoic acid | To treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C | 2/21/2020 | ||
| 50 | Lactitol | To treat chronic idiopathic constipation (CIC) in adults | 02-12-2020 | ||
| 51 | Tazemetostat | To treat epithelioid sarcoma | 1/23/2020 | ||
| 52 | Teprotumumab-trbw | To treat Thyroid eye disease | 1/21/2020 | ||
| 53 | Avapritinib | To treat adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) | 01-09-2020 |